Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders

Ling Zhang, Gang Wang, Jiong Luo, Qing-E Zhang, Qian Zhao, Qi-Ying Deng, Xin Ma Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of China Background: Although quetiapine has often been used as monotherapy or adjunctive therapy in bipola...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang L, Wang G, Luo J, Zhang QE, Zhao Q, Deng QY, Ma X
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f81d9626778c481a8680df84899aaba8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f81d9626778c481a8680df84899aaba8
record_format	dspace
spelling	oai:doaj.org-article:f81d9626778c481a8680df84899aaba82021-12-02T04:29:45ZRetrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders1176-63281178-2021https://doaj.org/article/f81d9626778c481a8680df84899aaba82013-04-01T00:00:00Zhttp://www.dovepress.com/retrospective-analysis-of-factors-associated-with-quetiapine-dosage-in-a12873https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Ling Zhang, Gang Wang, Jiong Luo, Qing-E Zhang, Qian Zhao, Qi-Ying Deng, Xin Ma Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of China Background: Although quetiapine has often been used as monotherapy or adjunctive therapy in bipolar disorder, there is very limited clinical evidence regarding prescribing practices for quetiapine as maintenance treatment for bipolar disorder. Methods: We reviewed the inpatient and outpatient records of 175 Chinese patients who received treatment with quetiapine for bipolar disorder both during and following hospitalization. We compared patients treated with high-dose (>300 mg/day) and low-dose (≤300 mg/day) quetiapine during the acute treatment phase and in the subsequent 6 months of maintenance treatment, with assessments at months 1, 3, and 6. Multifactor logistic regression analysis was performed to identify factors associated with quetiapine dosage. Results: The proportion of patients receiving combination therapy of quetiapine and a mood stabilizer as acute and maintenance treatment was 99.4% and 84.6%, respectively. The mean dose of quetiapine when used for acute treatment in the 175 patients was 395.7 mg/day. The following factors were found to be independently associated with use of high-dose quetiapine: male gender (odds ratio [OR] 2.712, 95% confidence interval [CI] 1.372–5.362, P < 0.01), a manic or mixed episode (OR 2.786, 95% CI 1.362–5.699, P < 0.01), and psychotic features (OR 2.658, 95% CI 1.318–5.361, P < 0.01). In the subsequent 6 months, the mean dose of quetiapine prescribed steadily decreased to 375.0 mg/day, 330.6 mg/day, and 293.7 mg/day at months 1, 3, and 6. The main factors associated with high-dose quetiapine in maintenance treatment were male gender (month 1, OR 2.761; month 3, OR 2.583; month 6, OR 2.686; P < 0.01) and a manic or mixed episode (month 1, OR 2.626; month 3, OR 2.334; P < 0.01). Conclusion: Higher doses of quetiapine (>300 mg/day) are more likely to be prescribed to patients who are male, those who are experiencing a manic or mixed episode, and those who have psychotic features during acute treatment of bipolar disorder. For patients who remain clinically stable during the subsequent months, the quetiapine dose should be adjusted according to patient gender and the most recent type of episode experienced. Keywords: quetiapine, bipolar disorder, acute treatment, maintenance treatment, dosageZhang LWang GLuo JZhang QEZhao QDeng QYMa XDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 575-580 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Zhang L Wang G Luo J Zhang QE Zhao Q Deng QY Ma X Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
description	Ling Zhang, Gang Wang, Jiong Luo, Qing-E Zhang, Qian Zhao, Qi-Ying Deng, Xin Ma Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of China Background: Although quetiapine has often been used as monotherapy or adjunctive therapy in bipolar disorder, there is very limited clinical evidence regarding prescribing practices for quetiapine as maintenance treatment for bipolar disorder. Methods: We reviewed the inpatient and outpatient records of 175 Chinese patients who received treatment with quetiapine for bipolar disorder both during and following hospitalization. We compared patients treated with high-dose (>300 mg/day) and low-dose (≤300 mg/day) quetiapine during the acute treatment phase and in the subsequent 6 months of maintenance treatment, with assessments at months 1, 3, and 6. Multifactor logistic regression analysis was performed to identify factors associated with quetiapine dosage. Results: The proportion of patients receiving combination therapy of quetiapine and a mood stabilizer as acute and maintenance treatment was 99.4% and 84.6%, respectively. The mean dose of quetiapine when used for acute treatment in the 175 patients was 395.7 mg/day. The following factors were found to be independently associated with use of high-dose quetiapine: male gender (odds ratio [OR] 2.712, 95% confidence interval [CI] 1.372–5.362, P < 0.01), a manic or mixed episode (OR 2.786, 95% CI 1.362–5.699, P < 0.01), and psychotic features (OR 2.658, 95% CI 1.318–5.361, P < 0.01). In the subsequent 6 months, the mean dose of quetiapine prescribed steadily decreased to 375.0 mg/day, 330.6 mg/day, and 293.7 mg/day at months 1, 3, and 6. The main factors associated with high-dose quetiapine in maintenance treatment were male gender (month 1, OR 2.761; month 3, OR 2.583; month 6, OR 2.686; P < 0.01) and a manic or mixed episode (month 1, OR 2.626; month 3, OR 2.334; P < 0.01). Conclusion: Higher doses of quetiapine (>300 mg/day) are more likely to be prescribed to patients who are male, those who are experiencing a manic or mixed episode, and those who have psychotic features during acute treatment of bipolar disorder. For patients who remain clinically stable during the subsequent months, the quetiapine dose should be adjusted according to patient gender and the most recent type of episode experienced. Keywords: quetiapine, bipolar disorder, acute treatment, maintenance treatment, dosage
format	article
author	Zhang L Wang G Luo J Zhang QE Zhao Q Deng QY Ma X
author_facet	Zhang L Wang G Luo J Zhang QE Zhao Q Deng QY Ma X
author_sort	Zhang L
title	Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
title_short	Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
title_full	Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
title_fullStr	Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
title_full_unstemmed	Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
title_sort	retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/f81d9626778c481a8680df84899aaba8
work_keys_str_mv	AT zhangl retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders AT wangg retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders AT luoj retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders AT zhangqe retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders AT zhaoq retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders AT dengqy retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders AT max retrospectiveanalysisoffactorsassociatedwithquetiapinedosageintheacuteandsubsequentsixmonthmaintenancetreatmentofbipolardisorders
_version_	1718401225165111296

Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders

Ejemplares similares